Preclinical Differentiation between Apparently Safe and Potentially Hepatotoxic Applications of TRAIL Either Alone or in Combination with Chemotherapeutic Drugs

Tumor necrosis factor-related apoptosis-inducing ligand (TRAIL/Apo2L) exhibits potent antitumor activity on systemic administration in nonhuman primates without deleterious side effects for normal tissue. However, there is a controversy about the potential toxicity of TRAIL on human hepatocytes. The...

全面介紹

Saved in:
書目詳細資料
Main Authors: Tom M. Ganten, Ronald Koschny, Jaromir Sykora, Henning Schulze‐Bergkamen, Peter Büchler, Tobias L. Haas, Manuela B. Schader, Andreas Untergasser, Wolfgang Stremmel, Henning Walczak
格式: Artigo
語言:英语
出版: 2006
在線閱讀:https://doi.org/10.1158/1078-0432.ccr-05-2635
https://aacrjournals.org/clincancerres/article-pdf/12/8/2640/1968793/2640.pdf
標簽: 添加標簽
沒有標簽, 成為第一個標記此記錄!